Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huarui Lu

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Current Drug Targets|March 30, 2011
FOXO1: a potential target for human diseasesHuarui Lu, Haojie Huang
Plos One|August 18, 2012
Sensitivity to TOP2 targeting chemotherapeutics is regulated by Oct1 and FILIP1LHuarui Lu, Timothy C Hallstrom
The Journal of Biological Chemistry|July 9, 2013
The nuclear protein UHRF2 is a direct target of the transcription factor E2F1 in the induction of apoptosisHuarui Lu, Timothy C Hallstrom
Neoplasia (New York, N.Y.)|October 5, 2011
Inhibition of cyclin-dependent kinase phosphorylation of FOXO1 and prostate cancer cell growth by a peptide derived from FOXO1Huarui Lu, Ping Liu, Yunqian Pan, et al.
Cell Cycle (Georgetown, Tex.)|May 16, 2024
UHRF2 accumulates in early G<sub>1</sub>-phase after serum stimulation or mitotic exit to extend G<sub>1</sub> and total cell cycle lengthXiaohong Wang, Huarui Lu, Grace Sprangers, et al.
Cell Cycle (Georgetown, Tex.)|September 23, 2011
Jab1/CSN5 mediates E2F dependent expression of mitotic and apoptotic but not DNA replication targetsHuarui Lu, Xudong Liang, Olga A Issaenko, et al.
International Journal of Cancer|January 13, 2011
Inhibition of ovarian cancer by RGD-P125A-endostatin-Fc fusion proteinsYawu Jing, Huarui Lu, Kailang Wu, et al.
Plos One|August 29, 2015
Rb1 and Pten Co-Deletion in Osteoblast Precursor Cells Causes Rapid Lipoma Formation in MiceEmma A Filtz, Ann Emery, Huarui Lu, et al.
Oncotarget|April 27, 2017
Retinoblastoma cells activate the AKT pathway and are vulnerable to the PI3K/mTOR inhibitor NVP-BEZ235Chencheng Xie, Matthew J Freeman, Huarui Lu, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 4, 2021
Retinoblastoma tumor cell proliferation is negatively associated with an immune gene expression signature and increased immune cellsAaron L Sarver, Chencheng Xie, Megan J Riddle, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Drug Targets|March 30, 2011
FOXO1: a potential target for human diseasesHuarui Lu, Haojie Huang
Plos One|August 18, 2012
Sensitivity to TOP2 targeting chemotherapeutics is regulated by Oct1 and FILIP1LHuarui Lu, Timothy C Hallstrom
The Journal of Biological Chemistry|July 9, 2013
The nuclear protein UHRF2 is a direct target of the transcription factor E2F1 in the induction of apoptosisHuarui Lu, Timothy C Hallstrom
Neoplasia (New York, N.Y.)|October 5, 2011
Inhibition of cyclin-dependent kinase phosphorylation of FOXO1 and prostate cancer cell growth by a peptide derived from FOXO1Huarui Lu, Ping Liu, Yunqian Pan, et al.
Cell Cycle (Georgetown, Tex.)|May 16, 2024
UHRF2 accumulates in early G<sub>1</sub>-phase after serum stimulation or mitotic exit to extend G<sub>1</sub> and total cell cycle lengthXiaohong Wang, Huarui Lu, Grace Sprangers, et al.
Cell Cycle (Georgetown, Tex.)|September 23, 2011
Jab1/CSN5 mediates E2F dependent expression of mitotic and apoptotic but not DNA replication targetsHuarui Lu, Xudong Liang, Olga A Issaenko, et al.
International Journal of Cancer|January 13, 2011
Inhibition of ovarian cancer by RGD-P125A-endostatin-Fc fusion proteinsYawu Jing, Huarui Lu, Kailang Wu, et al.
Plos One|August 29, 2015
Rb1 and Pten Co-Deletion in Osteoblast Precursor Cells Causes Rapid Lipoma Formation in MiceEmma A Filtz, Ann Emery, Huarui Lu, et al.
Oncotarget|April 27, 2017
Retinoblastoma cells activate the AKT pathway and are vulnerable to the PI3K/mTOR inhibitor NVP-BEZ235Chencheng Xie, Matthew J Freeman, Huarui Lu, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|March 4, 2021
Retinoblastoma tumor cell proliferation is negatively associated with an immune gene expression signature and increased immune cellsAaron L Sarver, Chencheng Xie, Megan J Riddle, et al.
Pageof 2